Search results for "R2"

HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness

2021

Simple Summary Breast cancer (BC) is not a single disease, but a group of different tumors, and altered HER2 expression defines a particularly aggressive subtype. Although HER2 pharmacological inhibition has dramatically improved the prognosis of HER2-positive BC patients, there is still an urgent need for improved knowledge of HER2 biology and mechanisms underlying HER2-driven aggressiveness and drug susceptibility. Emerging data suggest that the clinical efficacy of molecularly targeted therapies is related to their ability to target breast cancer stem cells (BCSCs), a population that is not only self-sustaining and able to differentiate into distinct lineages, but also contributes to tum…

Hidden biochemical action of Ethanol on colon carcinoma cell models

Colorectal cancer (CRC) is one of the most widespread cancers in the world. Numerous risk factors have been correlated with the development of CRC, including genetic factors, inflammation, intestinal microflora composition, as well as lifestyle factors, such as smoking, high consumption of red meats and alcohol intake. Epidemiological studies support the conclusion that chronic and heavy alcohol consumption increases the risk to develop CRC as well as favors the progression of this form of cancer. However, the biochemical mechanisms responsible for these events have not yet been fully clarified. The aim of my doctoral project was to study the effects of ethanol in human colorectal carcinoma…

Análisis inmunohistoquímico de mediadores moleculares implicados en angiogénesis LDH5 y VEGFR2/pKDR en pacientes con cáncer colorrectal avanzado: det…

2017

Tema. El esquema de tratamiento de primera línea estándar más utlizado para los pacientes diagnosticados de adenocarcinoma colorectal avanzado es en la actualidad la combinación de Oxaliplatino, Fluoropirimidinas y Bevacizumab. No todos los pacientes se benefician de igual manera, siendo necesarios identificar marcadores moleculares capaces de predecir el pronóstico y la posibilidad de respuesta. Objetivos. El objetivo de nuestro estudio es determinar el papel pronóstico y predictivo de la expresión inmunohistoquímica de dos proteínas implicadas en la angiogénesis y adaptación metabólica a la hipoxia tumoral: LDH5 y VEGFR/pKDR, en pacientes tratados con Oxaliplatino y Fluoropirimidinas con …

Papel de IRS2 en la reparación del daño hepático y cáncer

2019

La resistencia a insulina es una característica típica de la diabetes tipo 2 y la obesidad, patologías vinculadas a un alto riesgo del desarrollo de enfermedades crónicas hepáticas y hepatocarcinoma. Sin embargo, se desconoce el papel que la resistencia a insulina pueda ejercer durante el daño hepático crónico y durante la hepatocarcinogénesis, por lo que se ha abordado esta cuestión a través del estudio del substrato receptor de insulina 2 (IRS2), principal promotor de la señalización de insulina en el hígado. La experimentación llevada a cabo durante este proyecto muestra que la deleción del gen Irs2 en el modelo murino Irs2-/- impide la inducción de Fgf7 en células estromales durante el …

Molecular Subtypes, Metastatic Pattern and Patient Age in Breast Cancer: An Analysis of Italian Network of Cancer Registries (AIRTUM) Data

2021

Breast cancer stage at diagnosis, patient age and molecular tumor subtype influence disease progression. The aim of this study was to analyze the relationships between these factors and survival in breast cancer patients among the Italian population using data from the AIRTUM national database. We enrolled women with primary breast cancer from 17 population-based cancer registries. Patients were subdivided into older (>69 years), middle (50–69 years) and younger age groups (<50 years) and their primary tumors categorized into four molecular subtypes based on hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. There were 8831 patients diagnosed betwe…

Optimality of Increasing Stability for an Inverse Boundary Value Problem

2021

In this work we study the optimality of increasing stability of the inverse boundary value problem (IBVP) for the Schrödinger equation. The rigorous justification of increasing stability for the IBVP for the Schrödinger equation were established by Isakov [Discrete Contin. Dyn. Syst. Ser. S, 4 (2011), pp. 631--640] and by Isakov et al. [Inverse Problems and Applications, Contemp. Math. 615, American Math Society, Providence, RI, 2014, pp. 131--141]. In [Discrete Contin. Dyn. Syst. Ser. S, 4 (2011), pp. 631--640] and [Inverse Problems and Applications, Contemp. Math. 615, American Math Society, Providence, RI, 2014, pp. 131--141], the authors showed that the stability of this IBVP increases …

Aménités urbaines et périurbaines dans une aire métropolitaine de forme fractale

2002

In the THÜNEN tradition, Urban Economy is a striking abstraction, giving models that keep the main features of the wide diversity of real word cities. Nevertheless, this paradigm less suits the modern urban spatial structures (polycentrism, weak centripetal forces, etc.), particularly the peri-urban form of metropolitan areas, which are an urban/rural integrated space. In this paper, we propose a classical micro-economic urban model combined with a " SIERPINSKI's carpet " geometry, a fractal form which suits for fit together urban and rural areas in a hierarchical structure. Subject to a budget constraint, a household maximises a Cobb-Douglas/CES function, where household's taste for divers…

Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors

2011

Introduction: The use of monoclonal antibodies is one of the strategies for targeting the specific key points of the main pathways of cancer growth and survival, but only a few antibodies have offered a clear clinical benefit in the treatment of non-haematological malignancies. Areas covered: This review summarizes the general properties of monoclonal antibodies, including structure, nomenclature and production techniques. The antibodies approved for use in clinical practice for the treatment of non-haematological tumors and those antibodies still being developed in this setting are briefly described. The types of antibody fragments are also reported. Expert opinion: Monoclonal antibodies w…

Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration

2015

International audience; Members of the TGF-β superfamily transduce their signals through type I and II receptor serine/threonine kinases. The binding of activins to activin type IIA (ActRIIA) or type IIB (ActRIIB) receptors induces the recruitment and phosphorylation of an activin type I receptor (ALK4 and/or ALK7), which then phosphorylates the Smad2 and Smad3 intracellular signaling proteins. The regulation of members of the TGF-β family is known to be complex, because many proteins able to bind the ligands and inhibit their activities have been identified. Growth and differentiation factor 11 (Gdf11) belongs to the TGF-β family. GDF11, like other members of the TGF-β superfamily, is prod…

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.

2015

Abstract: Introduction: The identification of cell membrane-bound molecules with a relevant role in cancer cell survival prompted the development of moAbs to block the related pathways. In the last few years, the number of approved moAbs for cancer treatment has constantly increased. Many of these drugs significantly improved the survival outcomes in patients with solid tumours. Areas covered: In this review, all the FDA-approved moAbs in solid tumours have been described. This is an update of moAbs available for cancer treatment nowadays in comparison with the moAbs approved until few years ago. The moAbs under development are also discussed here. Expert opinion: The research on cancer ant…